<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="5484" whole_study_id="5484" phs="000160" v="1" p="1" createDate="2009-02-05T09:28:38-05:00" modDate="2019-07-19T13:30:23-05:00" maxParentChildStudyModDate="2019-07-19T13:30:23-05:00" handle="LOAD_6k_CIDR"><StudyInfo accession="phs000160.v1.p1" parentAccession="phs000160.v1.p1"><BioProject id="PRJNA75441" entrez_id="75441" type="bp_admin_access"/><BioProject id="PRJNA75443" entrez_id="75443" type="bp_data_submission"/><StudyNameEntrez>Genetic Consortium for Late Onset Alzheimer's Disease 6K</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><Description>
&lt;p&gt;&lt;b&gt;Multiplex Family Study&lt;/b&gt;&lt;br/&gt;The purpose of the NIA Genetics Initiative: Multiplex Family Study is to identify families with

 multiple members diagnosed with late-onset Alzheimer&amp;#39;s Disease. Families will be characterized clinically and blood samples will be

 collected to establish cell lines. If a blood sample is not available, autopsy samples will be collected for DNA extraction and storage.

 Our goal is to recruit 1,000 families over the course of the study. Clinical and demographic data from these families will be

 collected at the local site and coded data, without identifiers, will be sent and included in a national database of families

 with Alzheimer&amp;#39;s Disease. This database, along with the biological samples, will be housed at the National Cell

 Repository for Alzheimer&amp;#39;s Disease (NCRAD) at Indiana University. The Center or provider and the Cell Repository must sign a

 Material Transfer Agreement for shipment of biological samples and phenotypic data to NCRAD. The biological samples and data from

 these families will be available to qualified researchers, who must sign a Material Transfer Agreement before receiving DNA and data.

 An oversight committee known as the Cell Bank Advisory Committee (CBAC) will review and monitor the process of family identification

 and enrollment, data collection, the establishment of cell lines and access to samples.&lt;/p&gt;

 &lt;p&gt;&lt;b&gt;LOAD CIDR Project&lt;/b&gt;&lt;br/&gt;The first 362 families of the Multiplex Family Study (including 2,105 family members) were included in a

 6K SNP genome-wide scan at the NIH-supported, Center for Inherited Disease Research (CIDR). An additional 297 unrelated, healthy controls

 were also genotyped at CIDR.  The average age of onset of AD in the genotyped sample is 74 years and 62% of the sample is women. While

 primarily Caucasian, 3% are African-American, and 3% are of Hispanic ancestry.  72% of the families had at least 2 affected siblings,

 whereas 21% had 3 or more sampled affected individuals and 7% had 4 or more genotyped, affected family members.&lt;/p&gt;
 </Description><StudyHistory>
&lt;p&gt;In 2002, the National Institutes on Aging (NIA) Genetics Initiative for Late-Onset Alzheimer&amp;#39;s Disease (LOAD) was launched

 to expand the available resources for studies to identify the genes contributing to Alzheimer&amp;#39;s disease (AD). The NIA-LOAD Multiplex

 Family Study is a major component of the initiative.  NIA-LOAD is a multi-center study recruiting families with two or more affected

 siblings clinically or pathologically diagnosed with AD. Each Alzheimer&amp;#39;s Disease [Research] Centers (ADCs) have been responsible

 for recruitment and examination using a uniform protocol.  The National Cell Repository for AD (NCRAD) at Indiana University has been

 responsible for creating lymphoblastoid cell lines and storing clinical information from each family.  The NCRAD advisory board currently

 oversees distribution of clinical information and DNA to qualified genetic researchers.&lt;/p&gt;
 </StudyHistory><Attributions><Header title="Principal Investigators"><AttrName>Richard Mayeux, MD, MSc</AttrName><Institution>Columbia University, New York, NY, USA</Institution></Header><Header title="Principal Investigators"><AttrName>Tatiana Foroud, PhD</AttrName><Institution>National Cell Repository for Alzheimer's Disease, Indiana University, Indianapolis, IN, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Robert Green, MD, MPH</AttrName><Institution>Boston University, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Neil Kowall, MD</AttrName><Institution>Boston University, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Lindsay Farrer, PhD</AttrName><Institution>Boston University, Boston, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Donald E. Schmechel, MD</AttrName><Institution>Duke University, Durham, NC, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Martin Farlow, MD</AttrName><Institution>Indiana University, Indianapolis, IN, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Bernardino Ghetti, MD</AttrName><Institution>Indiana University, Indianapolis, IN, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Deborah Blacker, MD, ScD</AttrName><Institution>Massachusetts General Hospital, Charlestown, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>John Growdon, MD</AttrName><Institution>Massachusetts General Hospital, Charlestown, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Bradley T. Hyman, MD, PhD</AttrName><Institution>Massachusetts General Hospital, Charlestown, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Rudolph E. Tanzi, PhD</AttrName><Institution>Massachusetts General Hospital, Charlestown, MA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Bradley Boeve, MD</AttrName><Institution>Mayo Clinic, Rochester, MN, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Neill Graff-Radford, MD</AttrName><Institution>Mayo Clinic, Jacksonville, FL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Margaret Pericak-Vance, PhD</AttrName><Institution>Miami Institute for Human Genomics, University of Miami, Miami, FL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Jeremy M. Silverman, PhD</AttrName><Institution>Mount Sinai School of Medicine, New York, NY, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Michal Schnaider Beeri, PhD</AttrName><Institution>Mount Sinai School of Medicine, New York, NY, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Mary Sano, PhD</AttrName><Institution>Mount Sinai School of Medicine, New York, NY, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Nancy Johnson, PhD</AttrName><Institution>Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Medical School, Chicago, IL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Marsel Mesulam, MD</AttrName><Institution>Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Medical School, Chicago, IL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Sandra Weintraub, PhD</AttrName><Institution>Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Medical School, Chicago, IL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Eileen Bigio, MD</AttrName><Institution>Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Medical School, Chicago, IL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Jeffrey Kaye, MD</AttrName><Institution>Layton Center for Aging and Alzheimer's Disease, Oregon Health &amp; Science University, Portland, OR, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Patricia Kramer, PhD</AttrName><Institution>Layton Center for Aging and Alzheimer's Disease, Oregon Health &amp; Science University, Portland, OR, USA</Institution></Header><Header title="Co-Investigators"><AttrName>David A. Bennett, MD</AttrName><Institution>Rush University Medical Center, Chicago, IL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Lindy E. Harrell, MD, PhD</AttrName><Institution>University of Alabama at Birmingham, AL, USA</Institution></Header><Header title="Co-Investigators"><AttrName>George Bartzokis, MD</AttrName><Institution>David Geffen School of Medicine, University of California, Los Angeles, CA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>William Markesbery, MD</AttrName><Institution>University of Kentucky, Lexington, KY, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Charles Smith, MD</AttrName><Institution>University of Kentucky, Lexington, KY, USA</Institution></Header><Header title="Co-Investigators"><AttrName>John Q. Trojanowski, MD, PhD</AttrName><Institution>University of Pennsylvania, Philadelphia, PA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Vivianna Van Deerlin, MD, PhD</AttrName><Institution>University of Pennsylvania, Philadelphia, PA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Steven T. DeKosky, MD</AttrName><Institution>University of Pittsburgh, Pittsburgh, PA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Robert Sweet, MD</AttrName><Institution>University of Pittsburgh, Pittsburgh, PA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>I. Helena Chui, MD</AttrName><Institution>University of Southern California, Downey, CA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Arousiak Varpetian, MD</AttrName><Institution>University of Southern California, Downey, CA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Ramon Diaz-Arrastia, MD, PhD</AttrName><Institution>University of Texas Southwestern Medical Center at Dallas, TX, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Roger Rosenberg, MD</AttrName><Institution>University of Texas Southwestern Medical Center at Dallas, TX, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Thomas Bird, MD</AttrName><Institution>University of Washington, Seattle, WA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Murray Raskind, MD</AttrName><Institution>University of Washington, Seattle, WA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Gerard D. Schellenberg, PhD</AttrName><Institution>University of Washington, Seattle, WA, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Alison Goate, DPhil</AttrName><Institution>Washington University School of Medicine, St. Louis, MO, USA</Institution></Header><Header title="Co-Investigators"><AttrName>John Morris, MD</AttrName><Institution>Washington University School of Medicine, St. Louis, MO, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Marcelle Morrison-Bogorad, PhD</AttrName><Institution>National Institute on Aging, National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Marilyn Miller, PhD</AttrName><Institution>National Institute on Aging, National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Co-Investigators"><AttrName>Creighton H. Phelps, PhD</AttrName><Institution>National Institute on Aging, National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source for Genotyping"><AttrName>HHSN268200782096C. "NIH contract High throughput genotyping for studying the genetic contributions to human disease"</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header></Attributions><StudyURLs><Url name="The Alzheimer's Disease Genetics Initiative" url="http://niageneticsinitiative.org"/></StudyURLs><Publications><Publication><Pubmed pmid="19001172"/></Publication></Publications><Funding>U24AG026395</Funding></StudyInfo><Authority><ICs><IC id="16" name="NIA" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="MAYEUX" aid="2" auth="eRA" login="MAYEUX" fname="Richard" lname="Mayeux" email="rpm2@columbia.edu"><Role>PI</Role><Organization>COLUMBIA UNIVERSITY HEALTH SCIENCES</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010063767" aid="1" auth="cit" login="rossiw" fname="Winifred" mname="Kathleen" lname="Rossi" email="winnie_rossi@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>INSTRUCTIONS:  This study has not provided a suggested acknowledgement statement. However, Approved Users are expected to acknowledge the Submitting Investigator(s) who submitted data from the original study to an NIH-designated data repository, the primary funding organization that supported the Submitting Investigator(s), and the NIH-designated data repository (e.g., dbGaP).  The acknowledgment statement should include the dbGaP accession number to the specific version of the dataset(s) analyzed.</acknowledgement_statement><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="50" CGType="cg_class_other" title="General Research Use" name="GRU" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Subject consented to Alzheimer disease research conducted by non-profit and for-profit (pharmaceutical and biotechnology companies) organizations. Consented to genetic research of any human diseases conducted by non-profit and for-profit (pharmaceutical and biotechnology companies) organizations.</Use-Restriction></ConsentGroup><ConsentGroup uid="51" CGType="cg_class_other" title="Non-Profit Use" name="NPU" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Subject consented to Alzheimer disease research and genetic research of any human disease at non-profit organizations only.</Use-Restriction></ConsentGroup><ConsentGroup uid="52" CGType="cg_class_other" title="Alzheimer Disease Only" name="ALZ" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Subject consented to Alzheimer disease research only at non-profit and for-profit (pharmaceutical and biotechnology companies) organizations.</Use-Restriction></ConsentGroup><ConsentGroup uid="53" CGType="cg_class_other" title="Alzheimer Disease and Non-Profit Use Only" name="ALZ_NPU" dac_uid="57" dac_name="JAAMH" irb-approval-required="No"><Use-Restriction>Subject consented to Alzheimer disease research only at non-profit organizations.</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="50"><StudyTo study_uid="10253" name="dbGaP Collection: Compilation of Individual-Level Genomic Data for General Research Use" accession="phs000688.v1"><ConsentGroupTo uid="1115" name="GRU"/></StudyTo></ConsentGroupLink></ConsentGroupLinks></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>